Gerard Espinosa Selected Research

Antiphospholipid Antibodies

9/2022	The clinical significance of low complement levels in patients with catastrophic antiphospholipid syndrome: A descriptive analysis of 73 patients from the "Catastrophic antiphospholipid syndrome registry".
4/2022	Antigens and Antibodies of the Antiphospholipid Syndrome as New Allies in the Pathogenesis of COVID-19 Coagulopathy.
1/2022	Persistent Antiphospholipid Antibodies Are Not Associated With Worse Clinical Outcomes in a Prospective Cohort of Hospitalised Patients With SARS-CoV-2 Infection.
1/2022	The presence of non-criteria manifestations negatively affects the prognosis of seronegative antiphospholipid syndrome patients: a multicenter study.
7/2021	Procoagulant microparticles are associated with arterial disease in patients with systemic lupus erythematosus.
4/2021	Beta-2-Glycoprotein-I Deficiency Could Precipitate an Antiphospholipid Syndrome-like Prothrombotic Situation in Patients With Coronavirus Disease 2019.
9/2020	Comparative study between two European inception cohorts of patients with early systemic lupus erythematosus.
11/2019	Plasma exchange in catastrophic antiphospholipid syndrome.
1/2018	The H1 haplotype of the endothelial protein C receptor protects against arterial thrombosis in patients with antiphospholipid syndrome.
1/2018	Comparative study between obstetric antiphospholipid syndrome and obstetric morbidity related with antiphospholipid antibodies.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gerard Espinosa Research Topics

Disease

36	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 09/2022 - 12/2002
28	Thrombosis (Thrombus) 01/2022 - 01/2002
15	Systemic Lupus Erythematosus (Libman-Sacks Disease) 09/2022 - 06/2005
12	Autoimmune Diseases (Autoimmune Disease) 11/2021 - 03/2007
10	COVID-19 04/2022 - 01/2020
9	Uveitis 11/2021 - 01/2013
8	Venous Thrombosis (Deep-Vein Thrombosis) 01/2019 - 01/2008
6	Systemic Scleroderma (Systemic Sclerosis) 01/2022 - 11/2011
6	Behcet Syndrome (Behcet's Syndrome) 11/2020 - 01/2013
6	Vasculitis (Vasculitides) 01/2020 - 08/2007
5	Infections 04/2022 - 03/2010
5	Inflammation (Inflammations) 01/2018 - 10/2010
4	Thrombotic Microangiopathies 09/2022 - 06/2007
4	Neoplasms (Cancer) 08/2016 - 04/2006
4	Thrombocytopenia (Thrombopenia) 10/2015 - 05/2010
3	Arthritis (Polyarthritis) 01/2022 - 09/2020
3	Hemorrhage 01/2021 - 03/2003
3	Posterior Uveitis 12/2020 - 10/2010
3	Macular Edema 12/2020 - 11/2013
3	Anterior Uveitis 12/2020 - 10/2017
3	Panuveitis 12/2020 - 10/2012
3	Rheumatoid Arthritis 05/2018 - 01/2012
3	Habitual Abortion (Recurrent Miscarriage) 12/2010 - 01/2008
2	Myositis (Idiopathic Inflammatory Myopathies) 01/2022 - 03/2014
2	Pulmonary Hypertension 01/2022 - 07/2010
2	Susac Syndrome 11/2021 - 01/2020
2	Aphthous Stomatitis (Aphthous Ulcer) 09/2020 - 01/2020
2	Fever (Fevers) 01/2020 - 07/2015
2	Osteoporosis 01/2020 - 01/2020
2	Lupus Nephritis 12/2019 - 05/2016
2	Hemolytic Anemia 10/2015 - 02/2015
2	Thrombophilia 07/2014 - 11/2013
2	Chagas Disease (American Trypanosomiasis) 01/2013 - 04/2010
2	Septic Shock (Toxic Shock Syndrome) 08/2012 - 08/2007
2	Lymphoma (Lymphomas) 01/2012 - 12/2002
2	Systemic Inflammatory Response Syndrome (Sepsis Syndrome) 03/2010 - 12/2006

Drug/Important Bio-Agent (IBA)

31	Antiphospholipid AntibodiesIBA 09/2022 - 03/2003
11	AntibodiesIBA 04/2022 - 01/2008
9	Lupus Coagulation Inhibitor (Lupus Anticoagulant)IBA 08/2016 - 12/2002
6	Adalimumab (Humira)FDA Link 11/2021 - 10/2012
6	Anticardiolipin AntibodiesIBA 11/2013 - 03/2003
5	AntigensIBA 04/2022 - 11/2010
5	Proteins (Proteins, Gene)FDA Link 02/2022 - 05/2010
5	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2021 - 08/2007
5	GlucocorticoidsIBA 01/2020 - 06/2008
5	CytokinesIBA 09/2019 - 12/2006
4	Immunoglobulin G (IgG)IBA 01/2022 - 01/2012
4	Prothrombin (Factor II)IBA 04/2021 - 03/2013
4	Immunomodulating AgentsIBA 02/2021 - 10/2017
4	Rituximab (Mabthera)FDA Link 12/2019 - 09/2013
4	AutoantibodiesIBA 09/2019 - 01/2012
4	Immunosuppressive Agents (Immunosuppressants)IBA 01/2019 - 06/2008
3	Heparin (Liquaemin)FDA LinkGeneric 01/2021 - 01/2015
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2020 - 05/2011
3	AnticoagulantsIBA 01/2019 - 07/2014
3	Vitamin K FDA Link 01/2019 - 03/2013
3	Pharmaceutical PreparationsIBA 01/2016 - 04/2014
3	HLA-B Antigens (HLA-B)IBA 11/2015 - 01/2014
3	factor V LeidenIBA 11/2013 - 03/2013
3	beta 2-Glycoprotein I (Apolipoprotein H)IBA 12/2010 - 01/2008
2	Complement System Proteins (Complement)IBA 09/2022 - 04/2022
2	anti-scl-70 autoantibodiesIBA 06/2022 - 07/2015
2	Antinuclear AntibodiesIBA 11/2021 - 01/2020
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2021 - 01/2014
2	anti-dsDNA autoantibodyIBA 11/2021 - 07/2015
2	VaccinesIBA 10/2021 - 09/2021
2	Antigen-Antibody Complex (Immune Complex)IBA 04/2021 - 09/2011
2	Immunoglobulin A (IgA)IBA 04/2021 - 01/2012
2	Immunoglobulin M (IgM)IBA 04/2021 - 12/2002
2	Intravenous Immunoglobulins (IVIG)FDA Link 02/2021 - 01/2016
2	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2021 - 01/2019
2	Azathioprine (Imuran)FDA LinkGeneric 12/2020 - 10/2017
2	Methotrexate (Mexate)FDA LinkGeneric 12/2020 - 10/2017
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 12/2020 - 10/2017
2	Prostaglandins AIBA 11/2020 - 01/2020
2	Prednisone (Sone)FDA LinkGeneric 09/2020 - 05/2016
2	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 08/2020 - 01/2020
2	Warfarin (Coumadin)FDA LinkGeneric 01/2019 - 02/2014
2	tocilizumab (atlizumab)FDA Link 01/2018 - 11/2013
2	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 01/2018 - 11/2013
2	golimumab FDA Link 10/2017 - 04/2013
2	Glycoproteins (Glycoprotein)IBA 08/2016 - 05/2010
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 10/2015 - 02/2014
2	C-Reactive ProteinIBA 07/2015 - 01/2014
2	Thrombin FDA Link 07/2014 - 01/2002
2	Factor VIII (Coagulation Factor VIII)IBA 07/2014 - 11/2013
2	InterferonsIBA 04/2014 - 01/2014
2	Biological ProductsIBA 04/2014 - 04/2013
2	Protein SIBA 11/2013 - 03/2013
2	Infliximab (Remicade)FDA Link 04/2013 - 10/2010
2	benzonidazole (benznidazole)IBA 01/2013 - 04/2010
2	NifurtimoxIBA 01/2013 - 04/2010
2	Antiparasitic Agents (Antiparasitics)IBA 01/2013 - 04/2010
2	posaconazole FDA Link 01/2013 - 04/2010
2	Carboxypeptidase B2 (Thrombin Activatable Fibrinolysis Inhibitor)IBA 11/2010 - 12/2009

Therapy/Procedure

16	Therapeutics 04/2022 - 05/2010
3	Biological Therapy 09/2020 - 03/2007
3	Plasma Exchange 11/2019 - 09/2011
2	Drug Therapy (Chemotherapy) 08/2016 - 05/2016
2	Kidney Transplantation 01/2014 - 08/2012